Vaishali Pharma Limited - Company Profile

Q: Who are the current directors of Vaishali Pharma Limited?

The current directors of Vaishali Pharma Limited are Hemant Damodar Pathak, Manish Bhagwandas Ved, Vishwa Bipinbhai Mekhia, Dewansh Ajay Vasani, Bhaveshkumar Popatlal Upadhyay, Atul Arvind Vasani, Pratik Vikram Jakhelia, Jagruti Atul Vasani, Dewansh Ajay Vasani.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2008.

2008 Mumbai, Maharashtra, India Active

Last Updated: December 23, 2025

Access Report

About Vaishali Pharma Limited

Vaishali Pharma Limited, a active public limited company, was established on 25 April 2008 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: L52310MH2008PLC181632. Registered under ROC Roc Mumbai. it is listed on NSE: VAISHALI. It has an authorized capital of ₹27.00 Cr and a paid-up capital of ₹26.09 Cr.

Formerly known as Vaishali Pharma Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹71.89 Cr and a net worth of ₹40.53 Cr. Employing 15 professional, Its leadership includes Manish Bhagwandas Ved (Director), Dewansh Ajay Vasani (Director), Bhaveshkumar Popatlal Upadhyay (Director). Past directors included Akshay Jharkhandi, Ashvin Jamnadas Ganatra, Manish Bhagwandas Ved. It holds ₹21.33 Cr open charges and ₹15.12 Cr settled loans. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at 706 To 709, 7Th Fl, Aravali Busines Center, R. C. Patel Road, Off Sodawala Lane, Bor, Ivali West, Mumbai, Maharashtra, 400092.

Company Details

CIN/LLPIN
L52310MH2008PLC181632
Registration Number
181632
Incorporation Date
25 April 2008
Authorized Capital
₹27.00 Cr
Paid-Up Capital
₹26.09 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (NSE: VAISHALI)
Company Status
Active

Key Metrics

Authorised Capital ₹ 27.00 Cr as on 23-12-2025
Paid Up Capital ₹ 26.09 Cr as on 23-12-2025
Company Age 17 Year, 9 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 21.33 Cr as on 23-12-2025
Satisfied Charges ₹ 15.12 Cr as on 23-12-2025
Revenue Growth **** -7.37% (FY 2023)
Profit Growth **** 64.12% (FY 2023)
Ebitda **** 33.19% (FY 2023)
Net Worth 53.80% (FY 2023)
Total Assets -3.34% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Vaishali Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Vaishali Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Manish Bhagwandas Ved	Director	31 Dec 2019	Current
Dewansh Ajay Vasani	Director	26 Apr 2018	Current
Bhaveshkumar Popatlal Upadhyay	Director	28 Jan 2025	Current
Atul Arvind Vasani	Managing Director	25 Apr 2008	Current
Pratik Vikram Jakhelia	Director	10 Jul 2021	Current
Jagruti Atul Vasani	Whole-Time Director	12 Nov 2009	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Company Secretary	-	Past
Pramod Abcsdd	Additional Director	30 Sep 2020	Past
Pramod Abcsdd	Additional Director	30 Sep 2020	Past
Pramod Abcsdd	Additional Director	29 Sep 2018	Past
Pramod Abcsdd	Additional Director	02 Jan 2025	Past
Pramod Abcsdd	Director	12 Feb 2020	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vaishali Pharma.

Vaishali Pharma Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.37% decrease. The company also saw a substantial improvement in profitability, with a 64.12% increase in profit. The company's net worth Soared by an impressive increase of 53.8%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-7.37%

*******

Revenue from Operations

*******

-8.12%

*******

Total Assets

*******

-3.34%

*******

Profit or Loss

*******

64.12%

*******

Net Worth

*******

53.80%

*******

EBITDA

*******

33.19%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vaishali Pharma?

In 2023, Vaishali Pharma had a promoter holding of 26.74% and a public holding of 73.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹213,317,675.00

Satisfied Charges

₹151,200,591.00

Charges Breakdown by Lending Institutions

Others : 15.36 Cr
Yes Bank Limited : 4.23 Cr
L&T Housing Finance Limited : 1.75 Cr

Latest Charge Details

Date	Lender	Amount	Status
16 May 2025	Others	₹1.00 M	Open
29 Mar 2025	Yes Bank Limited	₹4.23 Cr	Open
30 Sep 2020	Others	₹2.60 M	Open
05 Jan 2019	Others	₹3.00 Cr	Open
31 Jan 2015	L&T Housing Finance Limited	₹1.75 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Vaishali Pharma?

Vaishali Pharma has a workforce of 15 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Vaishali Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaishali Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vaishali Pharma

Recent Activity within the Organization

Director Appointment

Progress on Dewansh Ajay Vasani was appointed as a Cfo was appointed as a Cfo on 04 Jun 2025 & has been associated with this company since 8 months 7 days . was documented.
04 Jun 2025
Charges

A charge with Others amounted to Rs. 0.10 Cr with Charge ID 101105558 was registered on 16 May 2025. was recorded as a recent event.
16 May 2025
Charges

A charge with Yes Bank Limited amounted to Rs. 4.23 Cr with Charge ID 101094862 was registered on 29 Mar 2025. was recorded as a recent event.
29 Mar 2025
Director Appointment

Progress on Bhaveshkumar Popatlal Upadhyay was appointed as a Director was appointed as a Director on 28 Jan 2025 & has been associated with this company since 1 year 12 days . was documented.
28 Jan 2025
Annual General Meeting

Progress on Vaishali Pharma Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was documented.
27 Sep 2024
Balance Sheet

The activity Vaishali Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
31 Mar 2024

Explore recent activity and updates - View Recent Activity